Classification of biliary tract cancer (BTC): Evaluation of all entities

Annals of Oncology

Volumn 20, Issue 6, 2009, Pages 1148-1149

  Tonini, G ^a   Fratto, M E ^a   Vincenzi, B ^a   Santini, D ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL;

BILE DUCT CANCER; BILE DUCT CARCINOMA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CHOLECYSTECTOMY; DRUG SENSITIVITY; GALLBLADDER CARCINOMA; HUMAN; INCIDENCE; NOTE; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIVITY; STONE FORMATION;

BILIARY TRACT NEOPLASMS; HUMANS;

EID: 66149108788     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp275     Document Type: Note

References (5)

1. Randi G, Malvezzi M, Levi F et al. Epidemiology of biliary tract Cancers: An update. Ann Oncol 2009; 20: 146-156.
2. He XR, Wu XP. Difference in biological characteristics and sensitivity to Chemotherapy and radiotherapy between intrahepatic and extrahepatic cholangiocarcinoma cells in vitro. Chin Med Sci J 2008; 23: 54-59.
3. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-125.
4. Japanese Society of Biliary Surgery. Classification of Biliary Tract Carcinoma, second English edition. Tokyo: Kanehara 2004.
5. Furuse J, Takada T, Miyazaki M et al. Guidelines for chemotherapy of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008; 15: 55-62.